[1]
M. Kiyani, O. Clanahan, and M. A. Silverman, “Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review”, J Hematol, vol. 15, no. 5, pp. 219–224, Jan. 2026, doi: 10.14740/jh2233.